Edition:
United Kingdom

Poxel SA (POXEL.PA)

POXEL.PA on Paris Stock Exchange

5.75EUR
19 Nov 2018
Change (% chg)

-- (--)
Prev Close
€5.75
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
48,308
52-wk High
€8.18
52-wk Low
€5.42

Chart for

About

Poxel SAS is a France-based company principally engaged in the biopharmaceutical sector. The Company develops drugs with a focus on Type 2 diabetes. The Company aims at developing drugs from preclinical to phase 2 clinical proof of concept. Its lead product, Imeglimin, is in clinical phase 2 study for Type 2 diabetes indication.... (more)

Overall

Beta: --
Market Cap(Mil.): €144.47
Shares Outstanding(Mil.): 22.93
Dividend: --
Yield (%): --

Financials

  POXEL.PA Industry Sector
P/E (TTM): -- 83.63 33.59
EPS (TTM): -0.96 -- --
ROI: -74.43 -0.64 15.05
ROE: -76.50 0.08 16.62

Earnings vs. Estimates